Strides Pharma debuts with an ESG rating of 76/100 in S&P Global’s CSA 2024 EP News Bureau Jan 22, 2025 Strides has secured a position in the 94th percentile among its peers in the DRG Global Pharmaceuticals industry
Biocon enters Dow Jones Sustainability Emerging Markets Index EP News Bureau Dec 2, 2021 The company made a formal submission for Corporate Sustainability Assessment for its listing on DJSI for the first time this year…
